Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06161480 · ClinicalTrials.gov registry record · NA

Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium

A NA study of Delirium, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT06161480: Completed NA study of Delirium, sponsored by Virginia Commonwealth University.

NCT06161480 is a NA study of Delirium that has completed, run by Virginia Commonwealth University. The registered enrollment target is 49 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06161480, a NA study of Delirium, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

The use of weighted blankets to avert or alleviate Delirium in Adult ICU patients.

Primary Outcome

Study Participants will be asked to complete a survey describing their experience with using the weighted blanket upon discharge from the ICU or if they stop using the weighted blanket, to determine if participants felt using the weighted blanket was beneficial to their overall health improvement. The full name is "Participant Weighted Blanket Satisfaction Survey." A likert scale (1-5) was used with 1 being less satisfied and 5 being higher satisfaction. There were 6 questions total. Total score

Conditions Studied

Interventions

  • DEVICE Weighted Blanket

Study Locations (1)

Virginia

  • VCU Health Systems - Richmond

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2023-10-06
Est. Completion 2024-12-12
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT06161480 record still lists

NCT06161480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Weighted Blanket is the first listed.

NCT06161480 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06161480 about?

NCT06161480 is a clinical study titled "Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium". The use of weighted blankets to avert or alleviate Delirium in Adult ICU patients.

What is the current status of trial NCT06161480?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2023-10-06. Estimated completion is 2024-12-12.

What conditions does trial NCT06161480 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT06161480?

The interventions under investigation include: Weighted Blanket (DEVICE).

Who is sponsoring clinical trial NCT06161480?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06161480 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06161480's enrollment target sits among peer trials

49 51st of 62 higher than 12 of 62 other Delirium trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06161480, the US trial registry maintained by the National Library of Medicine. NCT06161480 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.